Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Largemyd mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders

Human Molecular Genetics

Volumn 11, Issue 21, 2002, Pages 2673-2687

  Holzfeind, Paul J ^a   Grewal, Prabhjit K ^b   Reitsamer, Herbert A ^a   Kechvar, Jasmin ^a   Lassmann, Hans ^a   Hoeger, Harald ^a   Hewitt, Jane E ^b   Bittner, Reginald E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; DYSFERLIN; DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; GLYCOSYLTRANSFERASE; LAMININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; BRAIN CORTEX; BRAIN DISEASE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM CORTEX; COMPLEX FORMATION; CONTROLLED STUDY; ELECTRORETINOGRAM; ENZYME GLYCOSYLATION; EYE DISEASE; GENE DELETION; GENE DISRUPTION; GENE MUTATION; GENETIC CODE; HEART MUSCLE; HOMOZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; MOUSE; MOUSE STRAIN; MUSCLE DISEASE; MUSCULAR DYSTROPHY; NERVE CELL; NONHUMAN; PATHOLOGY; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RETINA; SKELETAL MUSCLE; SYNAPTIC TRANSMISSION; TONGUE; WESTERN BLOTTING;

ANIMALIA;

EID: 0036799939     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.21.2673     Document Type: Article

References (55)

1. Lane, P.W., Beamer, T.C. and Myers, D.D. (1976) Myodystrophy, a new myopathy on chromosome 8 of the mouse. J Hered., 67, 135-138.
2. Mathews, K.D., Rapisarda, D., Bailey, H.L., Murray, J.C., Schleper, R.L. and Smith, R. (1995) Phenotypic and pathological evaluation of the myd mouse. A candidate model for facioscapulohumeral dystrophy. J. Neuropathol. Exp. Neurol., 54, 601-606.
3. Meier, H. and MacPike, A.D. (1977) Myopathies caused by three mutations of the mouse. J. Hered., 68, 383-385.
4. Rayburn, H.B. and Peterson, A.C. (1978) Naked axons in myodystrophic mice. Brain Res., 146, 380-384.
5. Mathews, K.D., Mills, K.A., Bailey, H.L., Schelper, R.L. and Murray, J.C. (1995) Mouse myodystrophy (myd) mutation: refined mapping in an interval flanked by homology with distal human 4q. Muscle Nerve, S2, S98-S102.
6. Grewal, RK., Bolland, D.J., Todd, L.C. and Hewitt, J.E. (1998) High resolution mapping of mouse chromosome 8 identifies an evolutionary chromosomal breakpoint. Mamm. Genome, 9, 603-607.
7. Grewal, RK., Holzfeind, P.J., Bitmer, R.E. and Hewitt, J.E. (2001) Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat. Genet., 28, 151-154.
8. Grewal, P.K. and Hewitt, J.E. Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy. Biochim. Biophys. Acta, in press.
9. Peyrard, M., Seroussi, E., Sandberg-Nordqvist, A.-C., Xie, Y.-G., Han, F.-Y., Fransson, I., Collins, J., Dunham, I., Kost-Alimova, M., Imreh, S. et al. (1999) The human LARGE gene from 22q12.3-q13.1 is a new distinct member of the glycosyltransferase gene family. Proc. Natl Acad. Sci. USA, 96, 598-603.
10. Cohn, R.D. and Campbell, K.P. (2000) Molecular basis of muscular dystrophies. Muscle Nerve, 23, 1456-1471.
11. Durbeej, M. and Campbell, K.P. (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev., 12, 349-361.
12. Henry, M.D. and Campbell, K.P. (1999) Dystroglycan inside and out. Curr. Opin. Cell Biol., 11, 602-607.
13. Brockington, M., Yuva, Y., Prandini, P., Brown, S.C., Torelli, S., Benson, M.A., Herrmann, R., Anderson, L.V.B., Bashir, R., Burgunder, J.-M. et al. (2001) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 21 as a milder allelic variant of congenital muscular dystrophy MDCIC. Hum. Mol. Genet., 10, 2851-2859.
14. Brockington, M., Blake, D.J., Prandini, P., Brown, S.C., Torelli, S., Benson, M.A., Ponting, C.P., Estournet, B., Romero, N.B., Mercuri, E. et al. (2001) Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am. J. Hum. Genet., 69, 1198-1209.
15. Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M. et al. (2001) Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell, 1, 717-724.
16. Hayashi, Y.K., Ogawa, M., Tagawa, K., Noguchi, S., Ishihara, T., Nonaka, I. and Arahata, K. (2001) Selective deficiency of α-dystroglycan in Fukuyama-type congenitial muscular dystrophy. Neurology, 57, 115-121.
17. Toda, T., Kobayashi, K., Kondo-Iida, E., Sasaki, J. and Nakamura, Y. (2000) The Fukuyama congenital muscular dystrophy story. Neuromusc. Dis., 10, 153-159.
18. Kobayashi, K., Nakahori, Y, Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M. et al. (1998) An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature, 394, 388-392.
19. Aravind, L. and Koonin, E.V. (1999) The fakutin protein family - predicted enzymes modifying cell-surface molecules. Current Biol., 9, R836-R837.
20. Zhang, W., Betel, D. and Schachter, H. (2002) Cloning and expression of a novel UDP-GlcNAc: α-D-mannoside β-1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc: α-3-D-mannoside β-1,2-N-acetylglucosaminyltransferase I. Biochem. J, 361, 153-162.
21. Endo, T. (1999) O-Mannosyl glycans in mammals. Biochim. Biophys. Acta, 1473, 237-246.
22. Chiba, A., Matsumura, K., Yamada, H., Inazu, T., Shimizu, T., Kusunoki, S., Kanazawa, I., Kobata, A. and Endo, T. (1997) Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin. J Biol. Chem., 272, 2156-2162.
23. Sasaki, T., Yamada, H., Matsumura, K., Shimizu, T., Kobata, A. and Endo, T. (1998) Detection of O-mannosyl glycans in rabbit skeletal muscle α-dystroglycan. Biochim. Biophys. Acta, 1425, 599-606.
24. Smalheiser, N.R., Haslam, S.M., Sutton-Smith, M., Morris, H.R. and Dell, A. (1998) Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J. Biol. Chem., 273, 23698-23703.
25. Straub, V., Rafael, J.A., Chamberlain, J.S. and Campbell, K.P. (1997) Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol., 139, 375-385.
26. Michele, D.E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R.D., Satz, J.S., Dollar, J., Nishino, I., Kelley, R.I., Somer, H. et al. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature, 418, 417-422.
27. Ohlendieck, K. and Campbell, K.P. (1991) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell Biol., 115, 1685-1694.
28. Colognato, H. and Yurchenco, P.D. (2000) Form and function: The laminin family of heterotrimers. Dev. Dyn., 218, 213-234.
29. Xu, H., Wu, X.R., Wewer, U.M. and Engvall, E. (1994) Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nat. Genet., 8, 297-302.
30. 2-chain (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat. Genet., 11, 216-218.
31. 2J mice. Hum. Mol. Genet., 4, 1055-1061.
32. Muntoni, F. and Sewry, C.A. (1998) Congenital muscular dystrophy: from rags to riches. Neurology, 51, 14-16.
33. Lissitzky, J.C., Charpin, C., Bignon, C., Bouzon, M., Kopp, F., Delori, P. and Martin, P.M. (1988) Laminin biosynthesis in the extracellular matrix-producing cell line PFHR9 studied with monoclonal and polyclonal antibodies. Biochem. J., 250, 843-852.
34. Talts, J.F., Andac, Z., Göhring, W., Brancaccio, A. and Timpl, R. (1999) Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several extracellular matrix proteins. EMBO J., 18, 863-870.
35. Ervasti, J.M. and Campbell, K.P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol., 122, 809-823.
36. Ervasti, J.M., Burwell, A.L. and Geissler, A.L. (1997) Tissue-specific heterogeneity in α-dystroglycan sialoglycosylation. Skeletal muscle α-dystroglycan is a latent receptor for Vicia villosa, agglutinin b4 masked by sialic acid modification. J. Biol. Chem., 272, 22315-22321.
37. Pillers, D.M., Weleber, R.G., Woodward, W.R., Green, D.G., Chapman, V.M. and Ray, P.N. (1995) mdxCv3 mouse is a model for electroretinography of Duchenne/Becker muscular dystrophy. Invest. Ophthalmol. Vis. Sci., 36, 462-466.
38. Pillers, D.M., Bulman, D.E., Weleber, R.G., Sigesmund, D.A., Musarella, M.A., Powell, B.R., Murphey, W.H., Westall, C., Panton, C., Becker, L.E. et al. (1993) Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nat. Genet., 4, 82-86.
39. Nutting, D.F., MacPike, A.D. and Meier, H. (1980) The calcium content of various tissues from myodystrophic and dystrophic mice. J. Hered., 71, 15-18.
40. Straub, V., Duclos, F., Venzke, D.P., Lee, J.C., Cutshall, S., Leveille, C.J. and Campbell, K.P. (1998) Molecular pathogenesis of muscle degeneration in the δ-sarcoglycan-deficient hamster. Am. J Pathol., 153, 1623-1630.
41. Nadeau, J.H. (2001) Modifier genes in mice and humans. Nat. Rev. Genet., 2, 165-174.
42. Burkin, D.J., Wallace, G.Q., Nicol, K.J., Kaufman, D.J. and Kaufman, S.J. (2001) Enchanced expression of the α7β1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J. Cell Biol., 152, 1207-1218.
43. Newman, E.A. and Frishman, L.J. (1991) The b-wave. In Arden, G.B. (ed.), Principles and Practice of Clinical Electrophysiology of Vision. Mosby-Year Book, St Louis, MO.
44. Pillers, D.A.M. (1999) Dystrophin and the retina. Mol. Genet. Metab., 68, 304-309.
45. Moukhles, H., Roque, R. and Carbonetto, S. (2000) α-Dystroglycan isoforms are differentially distributed in adult rat retina. J. Comp. Neurol., 420, 182-194.
46. Cormand, B., Avela, K., Pihko, H., Santavuori, P., Talim, B., Topaloglu, H., de la Chapelle, A. and Lehesjoki, A.E. (1999) Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping. Am. J. Hum. Genet., 64, 126-135.
47. Le Roy, I., Roubertoux, P.L., Jamot, L., Maarouf, F., Tordjman, S., Mortaud, S., Blanchard, C., Martin, B., Guillot, P.V. and Duquenne, V. (1998) Neuronal and behavioral differences between Mus musculus domesticus (C57BL/6JBy) and Mus musculus castaneus (CAST/Ei). Behav. Brain Res., 95, 135-142.
48. Olson, E.C. and Walsh, C.A. (2002) Smooth, rough and upside-down neocortical development. Curr. Opin. Genet. Dev., 12, 320-327.
49. Cormand, B., Pihko, H., Bayes, M., Valanne, L., Santavuori, P., Talim, B., Gershoni-Baruch, R., Ahmad, A., van Bokhoven, H., Brunner, H.G. et al. (2001) Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology, 56, 1059-1069.
50. Kano, H., Kobayashi, K., Herrmann, R., Tachikawa, M., Manya, H., Nishino, I., Nonaka, I., Straub, V., Talim, B., Voit, T. et al. (2002) Deficiency of α-dystroglycan in muscle-eye-brain disease. Biochem. Biophys. Res. Commun., 291, 1283-1286.
51. Moore, S.A., Saito, F., Chen, J., Michele, D.E., Henry, M.D., Messing, A., Cohn, R.D., Ross-Barta, S.E., Westra, S., Williamson, R.A. et al. (2002) Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature, 418, 422-425.
52. Williamson, R.A., Henry, M.D., Daniels, K.J., Hrstka, R.F., Lee, J.C., Sunada, Y., Ibraghimov-Beskrovnaya., O. and Campbell, K.P. (1997) Dystroglycan is essential for early embryonic development: disruption of Reichart's membrane in Dag1-null mice. Hum. Mol. Genet., 6, 831-841.
53. Herrmann, R., Straub, V., Blank, M., Kutzick, C., Franke, N., Jacob, E.N., Lenard, H.G., Kröger, S. and Voit, T. (2000) Dissociation of the dystroglycan complex in caveolin-3 -deficient limb girdle muscular dystrophy. Hum. Mol. Genet., 9, 2335-2340.
54. Anderson, L.V., Davison, K., Moss, J.A., Young, C., Cullen, M.J., Walsh, J., Johnson, M.A., Bashir, R., Britton, S., Keers, S. et al. (1999) Dysferlin is a plasma membrane protein and is expressed early in human development. Hum. Mol. Genet., 8, 855-861.
55. Sotgia, F., Lee, J.K., Das, K., Bedford, M., Petrucci, T.C., Macioce, P., Sargiacomo, M., Bricarelli, F.D., Minetti, C., Sudol, M. et al. (2000) Caveolin-3 directly interacts with the C-terminal tail of β-dystroglycan. Identification of a central WW-like domain within caveolin family members. J. Biol. Chem., 275, 38048-38058.